Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma
- 20 August 2005
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (1), 49-56
- https://doi.org/10.1002/pros.20320
Abstract
BACKGROUND ELAC2, MSR1, and RNASEL are candidate genes for hereditary prostate carcinoma (HPC). While, studies have demonstrated that single nucleotide polymorphisms (SNPs) in these genes are associated with sporadic disease as well as HPC, these results are often not replicated in follow-up studies. Given that the majority of patients studied had localized disease and up to 50% of localized prostate cancer is clinically insignificant, the inability to replicate the initial findings may reflect that some subjects had indolent tumors. Herein, we examine patients with metastatic disease to determine if an association exists between HPC SNPs and unambiguously significant prostate cancer. METHODS We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays. RESULTS Only ELAC2 217L (37% cases vs. 29% controls (P = 0.034)) and RNASEL 541E (61% cases vs. 53% controls (P = 0.045)) were over-represented. Analysis of genotypes revealed that presence of the leucine ELAC2 allele (OR 1.54: 95% CI = 0.99–2.41, SS vs. SL, LL) and homozygosity for the glutamic acid RNASEL allele (OR 1.68: 95% CI = 1.04–2.70, EE vs. DE, DD) were associated with increased risk. Patients with both genotypes were of particularly high-risk (OR 2.66: 95% CI = 1.36–5.19). CONCLUSIONS These results suggest that, in a European-American population, ELAC2 217L and RNASEL 541E are associated with metastatic sporadic disease. ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.Keywords
This publication has 36 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancerThe Prostate, 2003
- No association of germline alteration of MSR1 with prostate cancer riskNature Genetics, 2003
- Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese menInternational Journal of Cancer, 2003
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- HPC2 Variants and Screen-Detected Prostate CancerAmerican Journal of Human Genetics, 2001
- Evaluation of Linkage and Association of HPC2/ELAC2 in Patients with Familial or Sporadic Prostate CancerAmerican Journal of Human Genetics, 2001
- Association of HPC2/ELAC2 Genotypes and Prostate CancerAmerican Journal of Human Genetics, 2000
- Evidence for a Prostate Cancer–Susceptibility Locus on Chromosome 20American Journal of Human Genetics, 2000
- Evidence for a Rare Prostate Cancer–Susceptibility Locus at Chromosome 1p36American Journal of Human Genetics, 1999